Pharvaris N.V.
World Rank (Jan-05-2024)
7,301
Market Cap (Jan-05-2024)
1.326 Billion USD
World Rank (Jul-30-2023)
11,900
Market Cap (Jul-30-2023)
0.573 Billion USD
World Rank (Dec-25-2022)
15,021
Market Cap (Dec-25-2022)
0.335 Billion USD
World Rank (Jan-07-2022)
11,928
Market Cap (Jan-07-2022)
0.64 Billion USD
Company Profile
Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
Company Website